PathKeeper Surgical Celebrates the First Spine Surgery Performed with the PathKeeper 3D Optical Navigation System in Massachusetts

PathKeeper Surgical, a privately-held, Israel-based, medical technology company, dedicated to improving the health of individuals around the world suffering from all spinal issues requiring surgery. While celebrating the first use of the PathKeeper 3D optical navigation system during a spinal fusion surgery at Southcoast Health’s St. Luke’s Hospital in New Bedford, Massachusetts, PathKeeper Surgical strives to make navigation-guided surgery available to any patient in all operating rooms.

The PathKeeper system was utilized to create a comprehensive surgical plan and accurately navigate the single-level, lumbar degenerative spinal fusion surgery at Southcoast Health’s St. Luke’s Hospital.

“The PathKeeper system addresses many of the intricacies of spine surgery and adjusts to individual patient needs with a high level of accuracy and no radiation during a crucial part of the surgical procedure,” said Matthew Philips, MD, Chief of Brain & Spine Services, Southcoast Health Neurosurgery, Dartmouth, MA. “We have already experienced the clinical benefits of incorporating the PathKeeper system into our spinal fusion surgeries at St. Luke’s Hospital.”

The PathKeeper system was designed to replace traditional navigation technology with a 3D optical navigation system that offers comprehensive surgical planning; active, independent, submillimeter registration and tracking of the patient anatomy and surgical instruments; pinpoint accuracy of device implantation; more efficient surgical workflow; elimination of radiation exposure during the surgical procedure; and a more economical price so both the hospital and ambulatory-surgical center operating rooms can incorporate this new technology.

“We are thrilled at the adoption of the PathKeeper system at Southcoast Health, which continues our expansion of the PathKeeper system to hospitals and surgery centers across the United States,” said Ryan LeBlanc, Chief Commercial Officer, PathKeeper Surgical. “The PathKeeper system is a game changer in driving improved clinical outcomes and economic value to patients and healthcare providers.”

PathKeeper Surgical received its FDA 510k clearance earlier this year for the PathKeeper system. The name PathKeeper effectively describes the essence of the system – a 3D optical navigation system that ‘keeps’ the surgical ‘path’ on course throughout the surgery.

Hot this week

Voluntary Recall Notifying Medtronic Insulin Pump Users of Potential Risks of Shortened Pump Battery Life

Medtronic plc voluntarily issued a field action starting on July 31, 2024, notifying global customers of its MiniMedâ„¢ 600 series or 700 series insulin pumps to follow their pump's built-in alerts and alarms for battery status and to contact Medtronic if they observe changes in the battery life of their pump

Medtronic Expands AiBLE Spine Surgery Ecosystem with New Technologies and Siemens Healthineers Partnership

New advancements in the AiBLE Spine Surgery ecosystem build upon the company's commitment to procedural innovation and execution

Axlab, Danish Medtech Pioneer, expands to US with Advanced Robotic Tissue Sectioning for Pathology Laboratories

Kris Rokke, National Sales Director for Axlab in the US. "My team and I are extremely excited and honored about this unique opportunity to also offer this advanced technology to labs across the US and thus contribute to the pathology labs of tomorrow."

Spartan Medical Broadens Single-Use Sterile Instrument Portfolio to Improve Outcomes, Increase Efficiency, and Generate Cost Savings

Spartan Medical products portfolio of single-use, sterile med tech includes micro and minor surgical convenience kits, kerrison rongeurs, spinal and general surgical retractors, dural repair kits, synthetic biologics, and a wide range of orthopedic pre-sterilized implants and devices.

Recor Medical Supports European Society of Cardiology’s Hypertension Guidelines

Record Medical notes the new guidelines, "2024 ESC Guidelines for the management of elevated blood pressure and hypertension," have been published online and recommend the consideration of renal denervation (RDN) as a safe and effective treatment option for patients who have uncontrolled resistant hypertension or those that have uncontrolled hypertension with a higher risk of cardiovascular disease, who express a preference to undergo RDN.